Search Results - "Stalenhoef, Anton F."

Refine Results
  1. 1

    Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline by Berglund, Lars, Brunzell, John D, Goldberg, Anne C, Goldberg, Ira J, Sacks, Frank, Murad, Mohammad Hassan, Stalenhoef, Anton F. H

    “…Objective: The aim was to develop clinical practice guidelines on hypertriglyceridemia. Participants: The Task Force included a chair selected by The Endocrine…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    What is the role of non-invasive measurements of atherosclerosis in individual cardiovascular risk prediction? by Ter Avest, Ewoud, Stalenhoef, Anton F H, de Graaf, Jacqueline

    Published in Clinical science (1979) (01-05-2007)
    “…Primary prevention of CVD (cardiovascular disease) is mainly based on the assessment of individual cardiovascular risk factors. However, often, only the most…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9

    Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL by Stalenhoef, Anton F H, de Graaf, Jacqueline

    Published in Current opinion in lipidology (01-08-2008)
    “…The magnitude of the contribution of serum triglycerides to cardiovascular disease risk and the mechanisms by which triglyceride-rich lipoproteins exert their…”
    Get full text
    Journal Article
  10. 10

    The Metabolic Syndrome and Its Traits as Risk Factors for Subclinical Atherosclerosis by Holewijn, Suzanne, den Heijer, Martin, Swinkels, Dorine W., Stalenhoef, Anton F. H., de Graaf, Jacqueline

    “…Context and objective: The metabolic syndrome (MetS) indicates an increased cardiovascular risk. The objective of the present study was to determine the impact…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Familial Combined Hyperlipidemia Is Associated With Alterations in the Cholesterol Synthesis Pathway by van Himbergen, Thomas M, Otokozawa, Seiko, Matthan, Nirupa R, Schaefer, Ernst J, Buchsbaum, Aaron, Ai, Masumi, van Tits, Lambertus J.H, de Graaf, Jacqueline, Stalenhoef, Anton F.H

    “…OBJECTIVES—Familial combined hyperlipidemia (FCH) is a common familial lipid disorder characterized by increases in plasma total cholesterol, triglyceride, and…”
    Get full text
    Journal Article
  13. 13

    Combining risk markers improves cardiovascular risk prediction in women by Holewijn, Suzanne, den Heijer, Martin, Kiemeney, Lambertus A, Stalenhoef, Anton F H, de Graaf, Jacqueline

    Published in Clinical science (1979) (01-01-2014)
    “…Cardiovascular risk stratification could be improved by adding measures of atherosclerosis to current risk scores, especially in intermediate-risk individuals…”
    Get more information
    Journal Article
  14. 14

    The benefit of statins in non-cardiac vascular surgery patients by Stalenhoef, Anton F.H., MD, PhD

    Published in Journal of vascular surgery (2009)
    “…There is overwhelming evidence that statins reduce morbidity and mortality in patients with coronary disease. Statins have also been shown to reduce the risk…”
    Get full text
    Journal Article
  15. 15

    Simvastatin Treatment for Inflammatory Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome by Simon, Anna, Drewe, Elizabeth, Meer, Jos W. M., Powell, Richard J., Kelley, Richard I., Stalenhoef, Anton F. H., Drenth, Joost P. H.

    Published in Clinical pharmacology and therapeutics (01-05-2004)
    “…Hyperimmunoglobulinemia D (hyper‐IgD) and periodic fever syndrome, a hereditary autoinflammatory syndrome, is characterized by lifelong recurrent episodes of…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The expression of type III hyperlipoproteinemia: involvement of lipolysis genes by HENNEMAN, Peter, VAN DER SMAN-DE BEER, Femke, SMELT, Augustinus H. M, HANIFI MOGHADDAM, Payman, HUIJTS, Petra, STALENHOEF, Anton F. H, KASTELEIN, John J. P, VAN DUIJN, Cornelia M, HAVEKES, Louis M, FRANTS, Rune R, WILLEMS VAN DIJK, Ko

    Published in European journal of human genetics : EJHG (01-05-2009)
    “…Type III hyperlipoproteinemia (HLP) is mainly found in homozygous apolipoprotein (APO) E2 (R158C) carriers. Genetic factors contributing to the expression of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Effects of ubiquinone (coenzyme Q10) on myopathy in statin users by Schaars, Carel F, Stalenhoef, Anton FH

    Published in Current opinion in lipidology (01-12-2008)
    “…Statins are associated with muscle complaints, including myositis. The mechanism through which statin use causes muscle toxicity is unknown. One of the…”
    Get full text
    Journal Article
  20. 20

    Paraoxonase (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women by van Himbergen, Thomas M, van der Schouw, Yvonne T, Voorbij, Hieronymus A.M, van Tits, Lambertus J.H, Stalenhoef, Anton F.H, Peeters, Petra H.M, Roest, Mark

    Published in Atherosclerosis (01-08-2008)
    “…Abstract There is strong evidence from both animal- and in vitro-models that paraoxonase (PON1) is involved in the onset of cardiovascular disease. In humans…”
    Get full text
    Journal Article